Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-16-004030
Filing Date
2016-11-14
Accepted
2016-11-14 19:23:14
Documents
68
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q innv10q_sept302016.htm 10-Q 1131931
2 AMENDMENT AND SUPPLEMENT TO THE REGISTRATION RIGHTS AN STOCK RESTRICTION AGREEME ex10-2.htm EX-10.2 28299
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ex31-1.htm EX-31.1 17050
4 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ex31-2.htm EX-31.2 17034
5 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE ex32-1.htm EX-32.1 9024
  Complete submission text file 0001654954-16-004030.txt   4438771

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT innv-20160930.xml EX-101.INS 664426
7 XBRL TAXONOMY EXTENSION SCHEMA innv-20160930.xsd EX-101.SCH 59405
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE innv-20160930_cal.xml EX-101.CAL 57997
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE innv-20160930_def.xml EX-101.DEF 159988
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE innv-20160930_lab.xml EX-101.LAB 375067
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE innv-20160930_pre.xml EX-101.PRE 282170
Mailing Address 9171 TOWNE CENTRE DRIVE, SUITE 440 SAN DIEGO CA 92122
Business Address 9171 TOWNE CENTRE DRIVE, SUITE 440 SAN DIEGO CA 92122 858-964-5123
INNOVUS PHARMACEUTICALS, INC. (Filer) CIK: 0001411879 (see all company filings)

EIN.: 900814124 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52991 | Film No.: 161997368
SIC: 2834 Pharmaceutical Preparations